AlphAIalphai — Financial news for AI agents
investing.comAUG 192 min read$EL

Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates

Estee Lauder's shares rose after the company forecast full-year profit above estimates, citing strong demand for premium fragrances and key market performance. Q4 EPS was $0.39, beating estimates by $0.07, with revenue at $3.63B. Fiscal 2027 EPS forecast is $3.10-$3.35, above the $3.18 analyst estimate. The company also raised its operating margin outlook and declared a $0.35 quarterly dividend.

Original reporting
investing.com
Published Aug 19, 2026, 10:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 11:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$EL
Bullish
high confidence
Mentioned
$EL
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$ELBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest the turnaround is gaining traction, likely prompting buying interest.

02

Market read

Strong earnings and upgraded guidance make EL a focal point for consumer discretionary investors.

03

What to watch

Potential headwinds from raw material price volatility and currency fluctuations.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Estee Lauder is executing a turnaround strategy focusing on premium fragrances and geographic diversification.

Company-level read

Ticker impact

$ELBullishHigh confidence
Context

Estee Lauder reported Q4 EPS beat and raised FY2027 adjusted EPS guidance to $3.10-$3.35, above consensus.

Expected impact

Potential price appreciation on the back of strong earnings and raised guidance.

Evidence & confidence

The company beat EPS and revenue estimates and lifted FY guidance, which historically drives buying pressure.

Market effects

Sector

Boosts sentiment for the beauty and consumer discretionary sector.

Regional

Positive for U.S. consumer stocks, especially premium cosmetics.

Global

May influence global luxury goods peers.

Counterpoint

What could challenge this read

Investors may question sustainability of margin expansion amid rising costs.

Key entities

  • Company
    Estee Lauder Companies Inc.

    Global beauty and cosmetics manufacturer.

  • Executive
    Stéphane de La Faverie

    CEO of Estee Lauder.

Read at source← All news

Also covered by

1 outlet

Related articles

AUG 20
$ELHighAI 8/10

Estée Lauder Q4 2026 earnings beat, fiscal 2027 profit forecast

Estée Lauder reported fiscal 2026 earnings of $2.51 per share, exceeding expectations, with revenue of $3.63 billion. The company forecasted fiscal 2027 EPS between $3.10 and $3.35, above analyst estimates. Fragrance sales grew 10%, while skin care increased 4%. Mainland China sales rose 9%. The stock gained 8% premarket.

yahoo.com2 min
AUG 20
$ELHighAI 9/10

Why Estee Lauder Rallied This Week

Estee Lauder (EL) shares rose 11.8% this week after its Q4 earnings beat estimates, with revenue up 6.5% to $3.63B and EPS up 333% to $0.39. The company also provided optimistic guidance, expecting 3-5% revenue growth and 24-34% EPS growth for the next fiscal year. Management highlighted $1.2B in cost cuts and increased customer investments.

fool.com2 min
AUG 20
$ELMed

Sources: Shein Aims to IPO on September 1

French regulators fined Boohoo 2.33 million euros for deceptive trade practices, including misleading sale prices and material descriptions. Estee Lauder forecasted annual profit above estimates, citing strong demand for premium fragrances and skincare. Shein aims for a $25 billion valuation in its Hong Kong IPO, down from $100 billion four years ago.

aawsat.com3 min
AUG 20
$MRNAHighAI 9/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) shares surged 176.97% to $174.38 after a successful cancer therapy trial with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01, reporting $3.63B revenue and raising its margin forecast. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min
AUG 20
$MRNAMed

Dow Jones Today: The Treasury Just Did Something the Bond Market Desperately Needed

The Treasury announced it would double buybacks of longer-term notes, causing 30-year Treasury yields to drop to 5.194% and the Dow Jones to close up 0.22%. Fed minutes indicated potential rate hikes if inflation persists. Moderna's stock surged 175% after successful cancer vaccine trial data. Bitcoin rose above $68,000, driven by Treasury optimism and crypto legislation interest.

financial-news.co.uk4 min
AUG 20
$MRNAMed

US stocks snap losing streak on Treasury move, solid profits

U.S. stocks rose after the Treasury announced plans to double purchases of longer-term Treasurys, easing bond market pressure. The S&P 500 gained 0.2%, ending a 3-day losing streak. Strong earnings from Estee Lauder, Target, and others also supported gains. Moderna and Merck surged on positive cancer vaccine trial results. The 10-year Treasury yield fell to 4.64% from 4.71%.

asahi.com3 min